All Stories

  1. Interaction Between Frailty and Renal Function in Patients with Heart Failure
  2. The Role of Albuminuria in Diagnosing and Stratifying Kidney Disease in Heart Transplant Recipients: A KDIGO Criteria‐Based Analysis
  3. Protocol Biopsies Reveal Progressive Arteriolar Thickening as a Predictor of Mortality in Kidney Transplant Recipients
  4. Extracorporeal Photopheresis for Refractory BK Virus-Associated Nephropathy in Kidney Transplantation
  5. Lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates
  6. Implementación de la técnica interna (in-house) de determinación del ADN libre del donante en la actividad clínica diaria: experiencia del Hospital Clínic de Barcelona
  7. Implementation of the in-house technique for the determination of donor-derived cell-free DNA in daily clinical practice: Experience from the Hospital Clinic of Barcelona
  8. Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology
  9. Comparative Effects of Acetate- and Citrate-Based Dialysates on Dialysis Dose and Protein-Bound Uremic Toxins in Hemodiafiltration Patients: Exploring the Impact of Calcium and Magnesium Concentrations
  10. Lipid and Immunophenotypic Profiles in Hemodialysis Patients with Citrate vs. Acetate Dialysates
  11. Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate
  12. Editorial: CaRe Me: improving the cardio-renal-metabolic care of patients through clinical and translational research
  13. Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study versus Acetate
  14. Comparación de la eficacia y seguridad de la nueva generación dializadores de helixona
  15. Correlación entre el sodio plasmático determinado por el laboratorio y el determinado por el monitor de hemodiálisis
  16. Tacrolimus’s Time Below Therapeutic Range Is Associated With Acute Pancreatic Graft Rejection and the Development of De Novo Donor-specific Antibodies
  17. Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients
  18. Most recently developed polyester polymer alloy dialyzer: A new medium cut‐off membrane?
  19. Latest Trends in Hemodiafiltration
  20. Latest Trends in Hemodiafiltration
  21. Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle
  22. Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function
  23. Practical implementation and clinical benefits of the new automated dialysate sodium control biosensor
  24. Comments on “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?”
  25. Comentarios a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
  26. Results of Salt Intake Restriction Monitored with the New Sodium Control Biosensor
  27. The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits
  28. Outcomes in older kidney recipients from older donors: A propensity score analysis
  29. Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study
  30. Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism—A Targeted Metabolomics Approach
  31. Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers
  32. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
  33. Comparison of four medium cut-off dialyzers
  34. Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach
  35. Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study
  36. Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer
  37. Tailoring the dialysate bicarbonate eliminates pre-dialysis acidosis and post-dialysis alkalosis
  38. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
  39. Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
  40. Cloudy fluid, cloudy diagnosis
  41. Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation
  42. The Case | Persistent fever in a hemodialysis patient
  43. Lipidic Profiles of Patients Starting Peritoneal Dialysis Suggest an Increased Cardiovascular Risk Beyond Classical Dyslipidemia Biomarkers
  44. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
  45. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients
  46. Acute hepatitis post arteriovenous graft thrombectomy of hemodialysis vascular access
  47. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients
  48. Efficacy and safety of the Clearum dialyzer
  49. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
  50. Rapid re‐transplantation safety following early kidney graft loss
  51. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
  52. Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?
  53. Evaluation and comparison of polysulfone TS‐UL and PMMA NF‐U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration
  54. Humoral response of mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
  55. A case of recurrent anemia due to chronic parvovirus B19 infection in a kidney transplant recipient. Can everolimus make a difference?
  56. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results
  57. Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening
  58. Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)
  59. Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration
  60. Preliminary data on outcomes of SARS‐CoV‐2 infection in a Spanish single center cohort of kidney recipients
  61. Case report of COVID‐19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
  62. Comparison of Solute Removal Properties Between High‐Efficient Dialysis Modalities in Low Blood Flow Rate